Literature DB >> 27200928

Health Care Resource Use and Cost Of Multiple Sclerosis in Slovakia: Results from the National Cross-Sectional Study.

M Ondrusova1, M Psenkova1, V Donath2.   

Abstract

Entities:  

Year:  2014        PMID： 27200928     DOI： 10.1016/j.jval.2014.08.891

Source DB:  PubMed          Journal:  Value Health        ISSN： 1098-3015            Impact factor:   5.725


× No keyword cloud information.
  2 in total

Review 1.  Oral teriflunomide in the treatment of relapsing forms of multiple sclerosis: clinical evidence and long-term experience.

Authors:  Aaron E Miller
Journal:  Ther Adv Neurol Disord       Date:  2017-09-13       Impact factor: 6.570

2.  Cost-effectiveness of oral agents in relapsing-remitting multiple sclerosis compared to interferon-based therapy in Saudi Arabia.

Authors:  Mai F Alsaqa'aby; Varun Vaidya; Noura Khreis; Thamer Al Khairallah; Ahmed H Al-Jedai
Journal:  Ann Saudi Med       Date:  2017 Nov-Dec       Impact factor: 1.526
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.